GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis
ConclusionsAmong patients with type 2 DM, GLP-1R agonists are beneficial for primary stroke, MACE, and cardiovascular mortality prevention. Further RCTs are needed to evaluate their role for secondary stroke prevention.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Brain | Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Attack | Neurology | Statistics | Stroke